World E-Cigarette Alliance Urges EU to Resist Anti-E-Cigarette Pressure

Sep.01.2022
World E-Cigarette Alliance Urges EU to Resist Anti-E-Cigarette Pressure
World Vaping Alliance challenges EU’s ECI to ban tobacco/nicotine sales to those born after 2010 due to misleading information.

The World Electronic Cigarette Alliance has stated that the European Union Commission must bear the pressure against electronic cigarettes. Last week, the EU Commission announced the registration of a European Citizens' Initiative called "Call for a Smoke-Free Environment and for the Protection of the First European Smoke-Free Generation" by 2030.


The organizers of the proposal are a Spanish public health non-governmental organization called NoFumadores, which suggests banning the sale of tobacco and nicotine products to all citizens born after 2010.


Michael Land, head of the World Vaping Alliance, stated that "this initiative highlights the widespread misinformation regarding different nicotine products. It would be unfair to take a one-size-fits-all approach to vastly different products. Almost all smoking-related harm comes from the thousands of other chemicals in tobacco smoke, not nicotine. Using alternative products such as e-cigarettes significantly reduces the risks and has been proven to be an effective method for quitting smoking." "I will do nothing and only sacrifice my life.


The World Vaping Alliance is questioning the practicality of age-based sales restrictions for e-cigarettes. They argue that such restrictions may prove ineffective in the long run, as stores would have to check identification for even 50-year-olds. This would result in the rules being ignored, thereby creating a huge black market. Both outcomes would be harmful to public health. Furthermore, intergenerational bans may be illegal in Europe as they go against the principle of equal treatment of EU citizens. Denying young people the opportunity to reduce harm from smoking is morally wrong. We should offer them every chance to quit smoking for good, rather than stigmatizing smokers.


The organizers now have six months to collect one million signatures from at least seven different member states in order to force the European Commission to respond to the proposal. Registering for the ECI is not an endorsement by the Commission. However, with the Tobacco Products Directive looming, e-cigarette users are calling on the European Commission to take a risk-based approach to each product.


The registration of this initiative indicates that the pressure on EU institutions to reduce harm is increasing, which is not a good sign for the upcoming update of the tobacco products directive. Future regulations must be based on science and the experiences of millions of consumers. Handling of products with lower harm must be different from cigarettes. Prohibition has never worked, and it won't work. It will only lead to huge unintended consequences, endangering public health. This is exactly the opposite of what we all want," added Michael Land.


Announcement:


This article is compiled from third-party information and is intended for the exchange and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The compilation of this article is solely for industry exchange and research purposes.


Due to limitations in translation ability, the translated article may not fully express the same meaning as the original. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai
Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand
Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand
Philip Morris International said its Swedish Match facility in Owensboro will adjust part of its production schedule this summer in response to changing market conditions. According to a notice the company gave union leadership and employees on April 22, parts of ZYN production will shift from a 24/7 schedule back to a 24/5 schedule. The ZYN Flagship department will return to a five-day, three-shift operation.
Apr.23 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands released a trading update on April 14, reiterating its FY26 guidance and saying its 2030 transformation has started positively. The company said it still expects low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% growth in Group adjusted operating profit, at least high-single-digit earnings per share growth, and at least GBP 2.2 billion in free cash flow for the full year.
Apr.14 by 2FIRSTS.ai
Brazilian Police Find More Than 40,000 E-Cigarettes in Truck With Hidden Safe
Brazilian Police Find More Than 40,000 E-Cigarettes in Truck With Hidden Safe
Military police in Brazil’s Paraná state found more than 40,000 e-cigarettes inside a truck with a hidden safe on April 8 in Campina Grande do Sul, in the Curitiba metropolitan area.
Apr.13 by 2FIRSTS.ai
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao argues that nicotine pouches are no longer a niche alternative, but a force quietly reshaping the future of tobacco retail. For distributors and retailers, the real risk is not missing a trend—it is moving too late, after regulation tightens, shelf space hardens and the market begins to choose its winners.
Mar.31 by Alan Zhao | 2Firsts Perspectives